Novo Can't Shake Bid To Invalidate Prandin Patent

Law360, New York (October 7, 2010, 12:00 PM EDT) -- A federal judge has rejected a bid by Novo Nordisk A/S to dismiss a five-year-old dispute with generics makers Sun Pharmaceutical Industries Ltd. and Caraco Pharmaceutical Laboratories Ltd. over the validity of a patent for diabetes drug Prandin.

Judge Avern Cohn of the U.S. District Court for the Eastern District of Michigan on Wednesday denied Novo’s motion to dismiss, which had argued that an actual controversy no longer existed with the generics companies.

Novo originally filed suit against Caraco in 2005, and later added Sun, alleging...
To view the full article, register now.